We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sabien Technology Group Plc | LSE:SNT | London | Ordinary Share | GB00BN6JG812 | ORD 3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.50 | 12.00 | 13.00 | 12.50 | 12.50 | 12.50 | 6,033 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSNT
RNS Number : 0940U
Sabien Technology Group PLC
27 July 2020
27 July 2020
Sabien Technology Group plc
("Sabien" or the "Company")
Update re. Suspension
Following the announcement on 20 January 2020 regarding the possible acquisition of Ptarmigan Health Destinations SA, the Company's shares were suspended from trading on AIM with immediate effect. This is because the transaction would be classified as a reverse takeover in accordance with the AIM Rules for Companies ("AIM Rules"). Under the AIM Rules, the Company has six months from the date of suspension to publish an admission document setting out, inter alia, details of the proposed transaction or confirm these discussions have ceased. If neither of these outcomes is achieved, trading in the Company's shares will be cancelled.
Due to market impact of Covid-19 the Company has been granted an extension from six to twelve months from 20 January 2020 for publishing such an admission document or to confirm discussions concerning a transaction have ceased.
For further information:
Hot Features
Premium
+44 20 7993
3700
Sabien Technology Group plc
Richard Parris, Chairman
+44 203 328
Allenby Capital Limited (Nominated Adviser) 5656
John Depasquale / Asha Chotai
Peterhouse Capital Limited (Broker) +44 207 469
Duncan Vasey/ Lucy Williams 0930
A copy of this announcement will be available
from the Company's website at www.sabien-tech.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
UPDEAAXKALAEEAA
(END) Dow Jones Newswires
July 27, 2020 02:00 ET (06:00 GMT)
1 Year Sabien Technology Chart |
1 Month Sabien Technology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
